The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases

被引:29
|
作者
Kiran, Tugce [1 ]
Demirkesen, Cuyan [1 ]
Eker, Candan [2 ]
Kumusoglu, Hakki [2 ]
Tuzuner, Nukhet [1 ]
机构
[1] Istanbul Univ, Dept Pathol, Cerrahpasa Med Fac, TR-34098 Istanbul, Turkey
[2] Medimiks Med Biotechnol, Res & Dev Lab, Istanbul, Turkey
关键词
IRF4; translocation; MUM1; Cutaneous lymphomas; CD30; ALCL; MUM1; LYMPHOMAS;
D O I
10.1016/j.leukres.2012.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Current laboratory technics, clinicopathologic findings cannot always reliably distinguish primary cutaneous CD30(+) lymphoproliferative disorders (LPD), such as lymphomatoid papulosis (LyP), primary cutaneous CD30(+) anaplastic large cell lymphoma (PCALCL), transformed mycosis fungoides (T-MF) and systemic ALK(-) anaplastic large cell lymphoma (ALCL) with skin involvement. We investigated the presence of IRF4 translocation with break apart DNA-FISH method of these entities according to the recent studies of Feldman et al. In our study group with 53 cases, the detection of IRF4 translocation had a specificity and positive predictive value for PCALCL of 100%. In contrast MUM1/IRF4 protein expression was distributed widely without any predictive value. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:396 / 400
页数:5
相关论文
共 50 条
  • [21] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 267A - 267A
  • [22] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Nagargoje, G
    Trzpuc, T
    Kampalath, B
    Abed, N
    Lorek, J
    Chang, C
    BLOOD, 2001, 98 (11) : 333A - 333A
  • [23] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    MODERN PATHOLOGY, 2002, 15 (01) : 267A - 267A
  • [24] IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases
    Pham-Ledard, Anne
    Prochazkova-Carlotti, Martina
    Laharanne, Elodie
    Vergier, Beatrice
    Jouary, Thomas
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (03) : 816 - 825
  • [25] The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders
    Wasco, Matthew J.
    Fullen, Douglas
    Su, Lyndon
    Ma, Linglei
    HUMAN PATHOLOGY, 2008, 39 (04) : 557 - 563
  • [26] IRF4 Translocations Are Specific for Cutaneous Anaplastic Large Cell Lymphoma in Skin Biopsies Involved by T-Cell Lymphoproliferative Disorders
    Wada, D.
    Law, M. E.
    de Souza, A.
    Weenig, R.
    Comfere, N.
    Macon, W. R.
    Erickson, L. A.
    Dogan, A.
    Feldman, A. L.
    LABORATORY INVESTIGATION, 2009, 89 : 289A - 289A
  • [27] MUM1/IRF4 Is Expressed in a Subset of Follicular Lymphoma with BCL6 Translocation and Short Survival
    Rogers, H. J.
    Bodo, J.
    Jin, T.
    O'Brien, T. E.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2009, 89 : 283A - 283A
  • [28] Is CD117 Expression Related with Plasma Cell Differentiation, IRF4/MUM1 and CD38 Expressions in Lymphoid Neoplasms?
    Kaygusuz, Guelsah
    Kuzu, Isinsu
    Kiremitci, Saba
    Kankaya, Duygu
    Biyikli, Zeynep
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2008, 38 (06) : 511 - 517
  • [29] Distinct Interaction Networks of the MUM1/IRF4 in B- and T-Cell Lymphomas Identified by Tandem Mass Spectrometry.
    Gabali, Ali
    Conlon, Kevin P.
    Fermin, Damian
    Basrur, Venkatesha
    Lim, Megan S.
    Elenitoba-Johnson, Kojo S. J.
    BLOOD, 2009, 114 (22) : 1509 - 1510
  • [30] MUM1/IRF4 immunolabeling of neoplastic Langerhans histiocytes in a putative case of canine Langerhans cell histiocytosis
    Klosowski, Marika L.
    Hughes, Kelly L.
    Moore, A. Russell
    VETERINARY CLINICAL PATHOLOGY, 2023, : 670 - 675